BAX 335 is an AAV8-based hemophilia B gene therapy vector with a self-complementary vector genome and an expression cassette designed to express a codon-optimized FIX Padua transgene from the liver-specific transthyretin (TTR) promoter/enhancer combination.13 Here, TTR is linked to hemophilia B.